Fatty Liver Disease: Evolving Demographics & Changing IR Practice

Coordinator(s)

• GW

  Gregory Woodhead, MD, PhD

  Assistant Professor, Interventional Radiology
  University of Arizona

  Disclosure(s): No relevant disclosure to display
• 

  Juan Gimenez, MD

  Interventional Radiologist
  Oschner Health

  Disclosure(s): No relevant disclosure to display

A global obesity epidemic is driving a rise in nonalcoholic fatty liver disease (NAFLD). In parallel, NASH cirrhosis is the fasted rising cause of HCC. Accordingly, the practice of IR will need to understand how treating patients with NAFLD may differ from other types of cirrhosis and other causes of HCC. Of note, the desert southwest, including the host state for SIR 2023, Arizona, has two ethnic groups with increased incidence of NAFLD/NASH: Native American and Hispanic populations.

Presentations:

• 1:00 PM – 1:10 PM

  Fatty Liver Disease and IR Practice: Overview and Updates from the Literature
  

  Speaker: Gregory J. Woodhead, MD, PhD – University of Arizona
• 1:10 PM – 1:20 PM

  Evolving demographics and healthcare disparities associated with NAFLD/NASH
  

  Speaker: Gina Landinez, MD (she/her/hers) – UCSF
• 1:20 PM – 1:30 PM

  Portal Hypertension and TIPS in NAFLD/NASH: Different Etiologies, Different Outcomes?
  

  Speaker: Keith Pereira, MD, DABR, RPVI – Saint Louis University
• 1:30 PM – 1:40 PM

  Hepatology Perspective on Fatty Liver Disease: Unique Demographics of the Desert Southwest & Strategies for Screening and Treatment
  

  Speaker: Naim Alkhouri, Chief Medical Officer (he/him/his) – Arizona Liver Health
• 1:40 PM – 1:50 PM

  NAFLD/NASH and the Etiology of HCC
  

  Speaker: Divya Kumari, MD – University of Chicago Medicine
• 1:50 PM – 2:00 PM

  Treatment Outcomes of NAFLD/NASH associated HCC
  

  Speaker: Juan Gimenez, MD – Oschner Health
• 2:00 PM – 2:10 PM

  Transplant Surgery Perspective on NAFLD/NASH
  

  Speaker: Jack Hannallah, MD, MBA, MPH – University of Arizona
• 2:10 PM – 2:20 PM

  NAFLD and Bariatric Embolization: Is there a role for IR in the prevention and early intervention of disease process?
  

  Speaker: Clifford Weiss, MD, FSIR, FCIRSE – Johns Hopkins Univeristy School of Medicine
• 2:20 PM – 2:30 PM

  Q & A